ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

FLYE vs TMO // GROSS PROFIT MARGIN

Fly-E Group Inc. (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: FLYE 0 — TMO 9
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (FLYE VS. TMO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC FLYE TMO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin ACTIVE 24.40% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -24.20% 9.30% -33.50 TMO /roic <GO>
EV/EBITDA & P/E Valuation — 30.4x — TIE /valuation <GO>
Free Cash Flow Yield — 2.40% — TIE /fcf-yield <GO>
Operating Margin -33.80% 17.40% -51.20 TMO /operating-margins <GO>
Net Profit Margin -48.60% 15.10% -63.70 TMO /net-margins <GO>
Revenue Growth (YoY) -25.00% 3.90% -28.90 TMO /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.24% -0.24 TMO /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.27 4.50 -4.23 TMO /balance-sheet <GO>
Piotroski F-Score Quality 1/9 8/9 -7.00 TMO /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 44.1 62.9 -18.79 TMO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 0.94 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 36.3x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $3.0M $262.22B -$262.21B TMO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR FLYE REV TMO REV FLYE GROSS % TMO GROSS % FLYE FCF TMO FCF
FY 2025 $19.1M $44.56B 24.4% — -$13.9M $6.29B
FY 2024 $25.4M $42.88B 41.1% — -$11.7M $7.27B
FY 2023 $32.2M $42.86B — — $4.3M $6.48B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
FLYE // BETA —
TMO // BETA 0.94